| Innate and adaptive immunity in inflammatory bowel disease A Geremia, P Biancheri, P Allan, GR Corazza, A Di Sabatino Autoimmunity reviews 13 (1), 3-10, 2014 | 982 | 2014 |
| Coeliac disease A Di Sabatino, GR Corazza The Lancet 373 (9673), 1480-1493, 2009 | 940 | 2009 |
| Post-splenectomy and hyposplenic states A Di Sabatino, R Carsetti, GR Corazza The Lancet 378 (9785), 86-97, 2011 | 723 | 2011 |
| A gut-vascular barrier controls the systemic dissemination of bacteria I Spadoni, E Zagato, A Bertocchi, R Paolinelli, E Hot, A Di Sabatino, ... Science 350 (6262), 830-834, 2015 | 550 | 2015 |
| Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, ... New England Journal of Medicine 372 (12), 1104-1113, 2015 | 475 | 2015 |
| Differential regulation of interleukin 17 and interferon γ production in inflammatory bowel disease L Rovedatti, T Kudo, P Biancheri, M Sarra, CH Knowles, DS Rampton, ... Gut 58 (12), 1629-1636, 2009 | 462 | 2009 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 435 | 2021 |
| Dendritic cells in intestinal homeostasis and disease M Rescigno, A Di Sabatino The Journal of clinical investigation 119 (9), 2441-2450, 2009 | 432 | 2009 |
| Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic … R Caccialanza, A Laviano, F Lobascio, E Montagna, R Bruno, S Ludovisi, ... Nutrition 74, 110835, 2020 | 338 | 2020 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 325 | 2021 |
| Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease A Di Sabatino, R Ciccocioppo, F Cupelli, B Cinque, D Millimaggi, ... Gut 55 (4), 469-477, 2006 | 319 | 2006 |
| The immune recognition of gluten in coeliac disease R Ciccocioppo, A Di Sabatino, GR Corazza Clinical & Experimental Immunology 140 (3), 408-416, 2005 | 275 | 2005 |
| Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control … SB Solerte, F D’Addio, R Trevisan, E Lovati, A Rossi, I Pastore, ... Diabetes care 43 (12), 2999-3006, 2020 | 261 | 2020 |
| European Crohn’s and Colitis Organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease F Rieder, G Latella, F Magro, ES Yuksel, PDR Higgins, A Di Sabatino, ... Journal of Crohn's and Colitis 10 (8), 873-885, 2016 | 240 | 2016 |
| Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn’s disease strictures A Di Sabatino, CL Jackson, KM Pickard, M Buckley, L Rovedatti, ... Gut 58 (6), 777-789, 2009 | 227 | 2009 |
| Small amounts of gluten in subjects with suspected nonceliac gluten sensitivity: a randomized, double-blind, placebo-controlled, cross-over trial A Di Sabatino, U Volta, C Salvatore, P Biancheri, G Caio, R De Giorgio, ... Clinical Gastroenterology and Hepatology 13 (9), 1604-1612. e3, 2015 | 226 | 2015 |
| Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease A Di Sabatino, R Ciccocioppo, B Cinque, D Millimaggi, R Morera, ... Gut 53 (1), 70-77, 2004 | 225 | 2004 |
| Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-α treatment G Bergamaschi, A Di Sabatino, R Albertini, S Ardizzone, P Biancheri, ... Haematologica 95 (2), 199, 2010 | 217 | 2010 |
| Autoimmune gastritis MV Lenti, M Rugge, E Lahner, E Miceli, BH Toh, RM Genta, C De Block, ... Nature Reviews Disease Primers 6 (1), 56, 2020 | 211 | 2020 |
| Functional modulation of Crohn’s disease myofibroblasts by anti-tumor necrosis factor antibodies A Di Sabatino, SLF Pender, CL Jackson, JD Prothero, JN Gordon, ... Gastroenterology 133 (1), 137-149, 2007 | 209 | 2007 |
